Antimicrobial Resistance in Developing Countries 2009
DOI: 10.1007/978-0-387-89370-9_25
|View full text |Cite
|
Sign up to set email alerts
|

Containment of Antimicrobial Resistance in Developing Countries and Lessons Learned

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
27
0
2

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(30 citation statements)
references
References 40 publications
1
27
0
2
Order By: Relevance
“…Finally, the financial burden that resistance imposes upon health services causes more hardship in poor countries. All these have been very recently reviewed [1], not only with regard to bacteria, but also to other microbial pathogens that are gaining resistance and that pose particular threats to the public health in developing countries. The current situation in Mexico is briefly reviewed here.…”
Section: Introductionmentioning
confidence: 99%
“…Finally, the financial burden that resistance imposes upon health services causes more hardship in poor countries. All these have been very recently reviewed [1], not only with regard to bacteria, but also to other microbial pathogens that are gaining resistance and that pose particular threats to the public health in developing countries. The current situation in Mexico is briefly reviewed here.…”
Section: Introductionmentioning
confidence: 99%
“…The structure of β-lactams is an analog of the pentapeptid precursors and therefore, it interferes with bacterial cell wall synthesis in the last stage, as it competes with the precursor molecule that is linking with the peptidoglycan for the PBP. The bacteria die as a result of impaired cell wall synthesis (Bush, 2012;Hollenbeck and Rice, 2012;Sosa, 2009 The wide usage of β-lactam antimicrobials in both human and veterinary medicine creates a selection pressure (Schwaber et al, 2005) and plays an important role in the development of different resistance mechanisms enabling the bacteria to overcome the drug effects (Babic et al, 2006). There are a number of different resistance mechanisms associated with β-lactam resistance.…”
Section: ß-Lactamsmentioning
confidence: 99%
“…There are a number of different resistance mechanisms associated with β-lactam resistance. The most important mechanism associated with β-lactam resistance in gram-negative bacteria such as E. coli, involves the inactivation of the antimicrobial by the production of β-lactamase enzymes that are capable of hydrolysing and inactivating the ß-lactam ring (Allocati et al, 2013;Bradford, 2001;Bush, 2010;Bush, 2012;Li et al, 2007;Seiffert et al, 2013;Sosa, 2009). Resistance may also occur due to mutations in the PBPs, decreased outer membrane permeability and multidrug efflux pumps (Babic et al, 2006;Bush, 2010;Woodford et al, 2007).…”
Section: ß-Lactamsmentioning
confidence: 99%
See 2 more Smart Citations